ABMD

Stock Market Analysis

A Look At Abiomed Before The $380/Share Buyout From Johnson & Johnson

<img class="img_50" src="https://static2.seekingalpha.com/images/users_profile/051/411/522/medium_pic.png">

by Zach Bristow
Contributor since 2020 / 2432 Followers

2 years ago

Summary: JNJ’s agreed acquisition of ABMD at $380 per share came as a surprise to

Stock Market Analysis

Abiomed: Correction Offers Good Buying Opportunity

by Alpine Capital
Contributor since 2018 / 718 Followers

2 years ago

<img src="/wp-content/uploads/2022/12/bullish.png" style="width:50px;margin-left:30px">

Summary: Abiomed’s Impella range of micro heart pumps enjoy rising demand in the marketplace. The

Stock Market Analysis

Abiomed: Small Premium For Access To ~11% Normalized ROIC

<img class="img_50" src="https://static2.seekingalpha.com/images/users_profile/051/411/522/medium_pic.png">

by Zach Bristow
Contributor since 2020 / 2432 Followers

2 years ago

<img src="/wp-content/uploads/2022/12/bullish.png" style="width:50px;margin-left:30px">

Summary: Abiomed came in with another set of robust earnings yesterday, with double-digit growth from

Stock Market Analysis

Abiomed’s Profit Growth Slows On R&D, Sales Hold Strong Despite Shortages

<img class="img_50" src="https://static.seekingalpha.com/images/users_profile/050/103/188/medium_pic.png">

by Valkyrie Trading Society
Contributor since 2019 / 3361 Followers

3 years ago

Summary: ABMD had a decent quarter where revenues grew nicely but profits languished due to

Stock Market Analysis

Abiomed’s Less Troubled 2020 Justifies Multiple, But Medium-Term Headwinds Mean Capital Risk

<img class="img_50" src="https://static.seekingalpha.com/images/users_profile/050/103/188/medium_pic.png">

by Valkyrie Trading Society
Contributor since 2019 / 3361 Followers

3 years ago

Summary: Abiomed is a company with a superb product in the mid-market space while what